WANG Ling, CHEN Ji-yan. ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease[J]. Journal of Evidence-Based Medicine, 2006, 6(6): 337-339. DOI: 10.3969/j.issn.1671-5144.2006.06.006
|
Citation:
|
WANG Ling, CHEN Ji-yan. ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease[J]. Journal of Evidence-Based Medicine, 2006, 6(6): 337-339. DOI: 10.3969/j.issn.1671-5144.2006.06.006
|
WANG Ling, CHEN Ji-yan. ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease[J]. Journal of Evidence-Based Medicine, 2006, 6(6): 337-339. DOI: 10.3969/j.issn.1671-5144.2006.06.006
|
Citation:
|
WANG Ling, CHEN Ji-yan. ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease[J]. Journal of Evidence-Based Medicine, 2006, 6(6): 337-339. DOI: 10.3969/j.issn.1671-5144.2006.06.006
|
DownLoad: